Kerry Gusler
Family Medicine · Henderson, KYNPI 1174044978
Payments from drug & device makers
Across 202 payments — averaging $16.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$465
- Lilly USA, LLC$460
- Novo Nordisk$399
- Pfizer$229
- Astellas Pharma US Inc$155
- AstraZeneca$141
- plus $1K from 26 others
What the payments were for
- Food & beverage$3,13797%
- Education$953%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 41 | $465 |
| Lilly USA, LLC | 31 | $460 |
| Novo Nordisk | 28 | $399 |
| Pfizer | 14 | $229 |
| Astellas Pharma US Inc | 5 | $155 |
| AstraZeneca | 10 | $141 |
| Amgen | 8 | $130 |
| Shield Therapeutics Inc | 4 | $123 |
| Medtronic | 4 | $118 |
| GSK | 6 | $95 |
| Abbott | 6 | $92 |
| Corcept Therapeutics | 5 | $89 |
| Bayer | 5 | $83 |
| Biohaven Pharmaceuticals, Inc. | 5 | $83 |
| Axsome Therapeutics, Inc. | 3 | $62 |
| Tolmar, Inc. | 4 | $59 |
| Novartis | 3 | $50 |
| Johnson & Johnson | 1 | $50 |
| Almatica Pharma LLC | 2 | $39 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $37 |
| Exact Sciences | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 2 | $33 |
| Verity Pharmaceuticals Inc. | 1 | $33 |
| Teva Pharmaceuticals USA, Inc. | 2 | $32 |
| Vertex | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Idorsia Pharmaceuticals US Inc | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
| Insulet Corporation | 1 | $17 |
| Merck | 1 | $14 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
| Currax Pharmaceuticals LLC | 1 | $14 |
How this compares
$3,232 in reported general payments places this provider in the 75th percentile of 1,559 family medicine providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 182 | $180,347 |
| EliquisApixaban | 227 | $146,698 |
| MounjaroTirzepatide | 121 | $128,376 |
| JardianceEmpagliflozin | 65 | $63,517 |
| TrulicityDulaglutide | 28 | $38,899 |
| JanuviaSitagliptin Phosphate | 42 | $32,477 |
| Tresiba Flextouch U-200Insulin Degludec | 24 | $28,016 |
| VraylarCariprazine Hcl | 19 | $27,039 |
| JatenzoTestosterone Undecanoate | 26 | $24,945 |
| FarxigaDapagliflozin Propanediol | 32 | $23,464 |
| RybelsusSemaglutide | 13 | $19,563 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 30 | $19,044 |
| MyrbetriqMirabegron | 24 | $18,527 |
| KerendiaFinerenone | 23 | $14,391 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 17 | $14,125 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $399 | $199,910195 claims |
| Lilly USA, LLCMounjaro, Trulicity | $460 | $167,275149 claims |
| PfizerEliquis | $229 | $146,698227 claims |
| AbbVieVraylar, Linzess, Synthroid | $465 | $39,333124 claims |
| MerckJanuvia | $14 | $32,47742 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $95 | $25,80545 claims |
| AstraZenecaFarxiga | $141 | $23,46432 claims |
| Astellas Pharma US IncMyrbetriq | $155 | $18,52724 claims |
| BayerKerendia | $83 | $14,39123 claims |
| Johnson & JohnsonXarelto | $50 | $11,10718 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Dexilant | $19 | $3,33711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,559 family medicine providers in Kentucky.
Other family medicine in Henderson
- Brian SmithVersailles$7.7M
- Barbara Fleming-PhillipsLexington$1.4M
- Christopher RhyneLouisville$1M
- Kruti PatelBurlington$463K
- Michael LovelaceLouisville$244K
- John RichardLexington$226K
- Diego MastronardiBowling Green$196K
- James TurnboPaducah$124K
- Eleida Tur OlivaLexington$113K
- Jeffrey GreenParis$103K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.